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Introduction: Critically ill patients and patients undergoing high-risk and major surgery, are instrumented with
intra-arterial catheters and invasive blood pressure is considered the ? gold standard ? for arterial pressure monitoring.
Nonetheless, artifacts due to inappropriate dynamic response of the fluid-filled monitoring systems may lead to
clinically relevant differences between actual and displayed pressure values. We sought to analyze the incidence
and causes of resonance/underdamping phenomena in patients undergoing major vascular and cardiac surgery.
Methods: Arterial pressures were measured invasively and, according to the fast-flush Gardner ? s test, each patient
was attributed to one of two groups depending on the presence (R-group) or absence (NR-group) of resonance/
underdamping. Invasive pressure values were then compared with the non-invasive ones.
Results: A total of 11,610 pulses and 1,200 non-invasive blood pressure measurements were analyzed in 300
patients. Ninety-two out of 300 (30.7%) underdamping/resonance arterial signals were found. In these cases
(R-group) systolic invasive blood pressure (IBP) average overestimation of non-invasive blood pressure (NIBP) was
28.5 (15.9) mmHg (P <0.0001) while in the NR-group the overestimation was 4.1(5.3) mmHg (P <0.0001). The mean
IBP-NIBP difference in diastolic pressure in the R-group was −2.2 (10.6) mmHg and, in the NR-group −1.1 (5.8)
mmHg. The mean arterial pressure difference was 7.4 (11.2) mmHg in the R-group and 2.3 (6.4) mmHg in the
NR-group. A multivariate logistic regression identified five parameters independently associated with underdamping/
resonance: polydistrectual arteriopathy (P =0.0023; OR = 2.82), history of arterial hypertension (P =0.0214; OR = 2.09),
chronic obstructive pulmonary disease (P =0.198; OR = 2.61), arterial catheter diameter (20 vs. 18 gauge) (P <0.0001;
OR = 0.35) and sedation (P =0.0131; OR = 0.5). The ROC curve for the maximal pressure? time ratio, showed an optimum
selected cut-off point of 1.67 mmHg/msec with a specificity of 97% (95% CI: 95.13 to 99.47%) and a sensitivity of 77%
(95% CI: 67.25 to 85.28%) and an area under the ROC curve by extended trapezoidal rule of 0.88.
Conclusion: Physicians should be aware of the possibility that IBP can be inaccurate in a consistent number of patients
due to underdamping/resonance phenomena. NIBP measurement may help to confirm/exclude the presence of this
artifact avoiding inappropriate treatments.Introduction
Arterial pressure measurement represents a mandatory
step in the evaluation of patients? hemodynamics be-
cause it gives primary information about the perform-
ance of the cardiovascular system and tissue perfusion
[1]. In every clinical condition, arterial pressure monitor-
ing should hence be as accurate as possible [2,3]. For this
reason, in critically ill patients and in patients undergoing* Correspondence: stefano-romagnoli@hotmail.com
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unless otherwise stated.high-risk and major surgery, direct intra-arterial pressure
measurement (invasive blood pressure, IBP) is considered
the gold standard, allowing beat-by-beat measures even in
patients receiving inotropic or vasoactive drugs, or in
cases of abrupt changes in blood volume or arterial tone,
or those with arrhythmias [3-5]. The alternative to IBP
monitoring is the non-invasive (NIBP) system (oscillo-
metric technique). However, NIBP measurement is not
continuous and, during hemodynamic instability, severe
hypotension, in conditions of increased arterial stiffness and
in obese patients, this technique is expected to be less ac-
curate than the invasive one [2,4-8]. These considerationsal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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rors, altered pulse travelling (arterial dissection or sten-
osis) and artifacts due to movement or inappropriate
dynamic response of the fluid-filled monitoring systems
(overdamping and underdamping) [9,10]. In 2011, we
demonstrated that in patients undergoing vascular sur-
gery, the incidence of arterial pressure artifacts due to
underdamping of the pressure transducer (or resonance
artifact) was as high as 34.9% [10]. The aim of this study
was to identify the global incidence of IBP measurement
errors due to underdamping/resonance artifacts in three
different categories of patients: patients undergoing vas-
cular surgery, patients undergoing cardiac surgery, and
patients admitted to a cardiac surgery ICU. Additional
aims included error quantification through the compari-
son of IBP and NIBP measurements, identification of
clinical and pharmacological independent predisposing
factors or other variables associated with underdamping/
resonance and analysis of the threshold value of the max-
imal pressure-time ratio (pressure rise during systole)
(dP/dtMAX) possibly suggesting underdamping/resonance
of the arterial pressure signal.
Materials and methods
A prospective observational cohort study was conducted.
The study was approved by the hospital ethics committee
of the Azienda Ospedaliero-Universitaria Careggi - Uni-
versity of Florence, and informed consent was obtained
by all participants. All consecutive patients with indwell-
ing radial arterial catheter as standard practice in vascu-
lar surgery and cardiac surgery operating theatres and
cardiac surgery ICU were enrolled in the study. The ex-
clusion criteria were: age <18 years, body mass index
≥30 Kg/m2, any type of arrhythmia or hemodynamic in-
stability (>5 mmHg variation in mean blood pressure)
during the period of data collection, presence of tissue
edema, an artery line different to the left or right radial
artery, overdamped arterial signals (according to a fast-
flush test), and the inability to measure NIBP in the
same arm as that in which the arterial line was placed.
Data acquisition has been performed by the investiga-
tors prior to anesthesia induction, during surgery, in
the ICU, with or without sedation. None of the investi-
gators was involved in the clinical management of the
patients.
A standard procedure was used for all measurement
collection. First, the arterial pressure transducer was lev-
eled and zeroed to the intersection of the anterior axil-
lary line and the fifth intercostal space. The investigators
then purged the system of any air bubble with a dedi-
cated inflated flush system set at 300 mmHg. Second, in-
vasive systolic blood pressure (Sys-IBP), diastolic blood
pressure (Dia-IBP), and mean blood pressure (Mean-
IBP) were measured by means of a radial artery catheter(Leadercath Arterial polyethylene catheter - 18 gauge,
10 cm length, 0.8 mm internal diameter ? 1.2 mm external
diameter or 20 gauge, 8 cm length, 0.6 mm internal diam-
eter ? 0.9 mm external diameter; Vygon, Ecouen, France),
connected to a disposable pressure transducer (Package
transducer Edwards; VAMP Plus system; Edwards Life-
sciences, Irvine, CA, USA) and measured with a Philips
MP60 IntelliVue monitor (Philips Medical System; Best,
The Netherlands). The signal was then directed via the an-
alogic output to a MostCare? pulse contour hemodynamic
monitoring system (Vygon, Vytech Health, Padova, Italy)
in order to measure the dP/dtMAX. This ratio represents
the maximal rate of pressure change over time between
two consecutive points during the systolic upstroke re-
corded at 1000 Hz: in a previous study [10] this parameter
was shown to be significantly higher in underdamped/res-
onant signals that in non-affected waveforms. Moreover,
the analog pressure signals were digitized using a multi-
function board (Multifunction Analog and Digital Board
RTI-800, Analog-Devices, Norwood, MA, USA), and re-
corded on a personal computer (LTE5000, Compaq,
Houston, TX, USA) for fast-flush test registration and
analysis [11] (Figure 1). The fast-flush test is the only
one that allows clinicians to evaluate, the appropriate-
ness of the dynamic response of the blood pressure
measuring system at the bedside. The Fn and the damp-
ing coefficient (β) must be measured. The test is de-
scribed elsewhere in details [9]: briefly, it is performed
by flushing saline with high pressure (300 mmHg) via
the flush system of the transducer. This, generates an
undershoot and overshoot of waves that will decay expo-
nentially in accordance with the β. The natural fre-
quency (Fn) can be measured by dividing the paper
speed (for example, 25 mm/sec) by the wavelength or
period (peak to peak distance in mm) generated by the
flush (Figure 2). Damping (anything that reduces energy
in an oscillating system) will reduce the amplitude of
the oscillations and some degree of damping is re-
quired in all systems (for example, friction in the fluid
pathway). The β can be derived from the amplitude ra-
tio (AR) of two consecutive resonant waves. AR is cal-
culated by dividing the smaller wave (second) by the
higher one (first) (Figure 2). Once the AR is measured,
the corresponding β is then taken from charts [9].
Finally, the Fn and the AR or the corresponding β can
be plotted in a specific graph that shows three areas:
adequate dynamic response, overdamping, underdamp-
ing [9] (Figure 3).
Blood pressure values were recorded for thirty seconds
each and the average value taken for analysis. Finally,
the systolic (Sys)-NIBP, diastolic (Dia)-NIBP, Mean-NIBP
values were measured and recorded (an average of four)
[12] immediately following each invasive data collection,
using the same arm as that in which the indwelling
Figure 1 Schematic representation of the patient? s connection to the Philips? monitor for invasive blood pressure (IBP) and non-invasive
blood pressure (NIBP) monitoring. MostCare? is connected via an analog output for the continuous recording, at 1,000 Hz, of the systemic arterial
pressure waves and DP/dtMAX computation. The analog pressure signals are recorded on a personal computer for fast-flush test registration and
analysis. Sys, systolic; Dia, diastolic; DP/dtMAX: maximal pressure-time ratio.
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cuff size and upper arm circumference was respected ac-
cording to current guidelines [6]. Mean blood pressure
was delivered by each monitor according to the manufac-
turer ? s algorithm, avoiding the application of any formula
based on systolic and diastolic values.Figure 2 Fast-flush test. Amplitude ratio (AR): A2 (3 mm)/A1 (7 mm) = 0.4
period (peak-to-peak distance) necessary for the natural frequency calculati
data can be then plotted into the diagram showed in Figure 3. N: normal QEach patient was then assigned to one of two groups
depending on the presence (R-group) or absence (NR-
group) of resonance/underdamping identified by the
fast-flush test [9]. In addition, a series of clinically rele-
vant variables were registered in order to evaluate a pos-
sible correlation with underdamping/resonance artifact.3. The corresponding damping coefficient is 0.28 [9]. P identifies the
on: paper speed/P. In the example, 25 (mm/sec)/2 mm= 12.5 Hz; these
RS complex.
Figure 3 Diagram showing the three areas for underdamped, overdamped, and optimally damped blood pressure signal. The black
arrows indicate the natural frequency and the damping coefficient of the example showed in Figure 2. The white point identifies an
underdamped/resonant arterial pressure signal.
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All data were analyzed using Stats Direct (Ver.2.5.8,
Bonville Chase Altrincham Cheshire, UK) and GraphPad
(Ver. Prism 4.0; San Diego, CA, USA). The single-sample
Kolmogorov-Smirnov test was used to test all data for nor-
mality. Continuous variables were expressed as mean (SD)
or median with interquartile range where applicable. For
dichotomous data, percentages were calculated. IBP and
NIBP values were compared using the two-sided paired
t-test in both the R-group and NR-group. Pairwise com-
parison was performed using the regression-based
Bland-Altman technique, which models the mean and
SD of the blood pressure differences as a function of the
averaged measurements obtaining the bias (mean differ-
ence between methods) and limits of agreement (LoA)
(calculated as the bias ? 1.96 SD of the measurement
differences) [13]. The unpaired t-test was used for the
identification of differences in norepinephrine infusion
between the R- and NR-groups. A two-sided P-value
<0.05 was considered to be statistically significant.
In order to define the possible clinical/pharmaco-
logical or technical factors associated with the resonance
phenomenon, we performed multivariable logistic re-
gression analysis (backward selection) (covariates were
retained in the model if the P-value was <0.1) with
underdamping/resonance as the dependent variable. Co-
linearity between variables was excluded before modeling
and none of the covariates was co-linear. The Hosmer andLemeshow goodness-of-fit test was performed and the
odds ratio (OR) and 95% CI was computed.
Sample size was calculated taking into consideration
that in a previous study from our department [10] systolic
pressure of arterial signals affected by underdamping/res-
onance had an SD of 44.4 mmHg and the difference be-
tween IBP with and without underdamping/resonance
was 15 mmHg. In order to repeat the same results, we cal-
culated that at least 70 patients in the resonant group
should have been enrolled to guarantee a 90% power de-
tecting a mean difference between IBP and NIBP of 15.61
mmHg with a significance level (alpha) of 0.05 (one-
tailed). Considering that in the reference paper, resonant
patients were 30% of the overall population, in order to
enroll all the required patients with underdamped/reson-
ant arterial signals we calculated that at least 235 patients
had to be enrolled.
Results
During the study period, 348 patients were consecutively
evaluated; of these, 48 were excluded for the following
reasons: age <18 years (2 patients), body mass index ≥30
Kg/m2 (10 patients), any type of arrhythmia or hemo-
dynamic instability (>5 mmHg variation in mean blood
pressure; 32 patients), or artery line other than left or right
radial (4 patients). No patient was excluded for overdamp-
ing. Three hundred patients were definitively enrolled in
the study. They were divided as follows: 1) patients
Table 1 Incidence of underdamping/resonance
Overall,
number (%)
R-group,
number (%)
NR-group,
number (%)
Overall 300 (100) 92 (30.7) 208 (69.3)
Vascular surgery theater 70 (23.3) 20 (21.7) 50 (24)
Cardiac surgery theater 97 (32.3) 27 (29.4) 70 (33.6)
Cardiac surgery ICU 133 (44.4) 45 (48.9) 88 (42.4)
R-group, patients with arterial signals affected by underdamping/resonance;
NR-group, patients without arterial pressure artifact.
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eous angioplasty and stenting for peripheral artery disease,
carotid artery angioplasty and stenting, open surgery ca-
rotid endarterectomy, abdominal endovascular and open
aortic repair) (n = 70; 23.3%); 2) patients undergoing
cardiac surgery (off-pump and on-pump coronary artery
bypass graft surgery, valvular surgery, aortic surgery,
combined interventions) (n = 97; 32.3%); 3) patients ad-
mitted to cardiac surgery ICU (different from the previous
group of patients) (n = 133; 44.4%) (Table 1). Patients?
characteristics are summarized in Table 2.
A total of 11,610 IBP pulses and 1,200 NIBP measure-
ments were performed, and the respective averages
included in the analysis. The global incidence of under-
damping/resonance was 30.7% (92 out of 300 patients)
with a rather homogeneous distribution among the dif-
ferent settings (vascular surgery theatre: 30%; cardiac
surgery theatre: 27.8%; cardiac surgery ICU: 33.8%).
Fast-flush test for these patients resulted in an Fn of
15.9 (6.12) Hz with an AR of 0.39 (0.07) and β of 0.29
(0.05). In both the R-group and the NR-group, Sys-, Dia-,
and Mean-BP measured by IBP were significantly different
from NIBP values (P <0.05) (Table 3). The comparison of
blood pressure by means of the Bland-Altman method
(Tables 3 and 4; Figure 4) showed a mean Sys-IBP over-
estimation (bias) of 28.5 mmHg (range 2 to 77 mmHg;
LoA ? 2.92 to 59.58 mmHg) in the R-group, while in the
NR-group the overestimation was 4.1 mmHg (range ? 15
to 15 mmHg; LoA ? 6.19 to 14.40 mmHg). The bias in
Dia-IBP was ? 2.2 (10.6) mmHg in the R-group (range ? 39
to ? 10 mmHg; LoA ? 23.42 to 14.81 mmHg) and ? 1.1
(5.8) mmHg in the NR-group (range ? 17 to 14 mmHg;
LoA ? 12.5 to 10.3 mmHg), while it was 7.4 (11.2) mmHg
(range ? 20 to 44 mmHg; LoA ? 14.98 to 29.50 mmHg)Table 2 Patients ? characteristics
Age, yr (SD); range Gender, male,
number/total; %
BSA
Overall 69 (11); 21 to 87 201/300; 67 1.8
Vascular surgery theater 72 (8); 51 to 87 56/70; 81.1 1.8
Cardiac surgery theater 67 (13); 21 to 87 67/97; 69 1.8
Cardiac ICU 68 (11); 25 to 86 79/133; 59 1.8
BSA, body surface area; LVEF, left ventricle ejection fraction; HR, heart rate.for Mean-IBP in the R-group and 2.3 (6.4) mmHg (range
? 13 to ? 20 mmHg; LoA ? 13.09 to 17.69 mmHg) in the
NR-group.
Of 300 patients 71 (23.6%) received a continuous infu-
sion of norepinephrine at a dose of 0.019 (0.043) μg/Kg/
minute. The R-group received a lower norepinephrine
dosage (0.01 (0.03) μg/Kg/minute;) than the NR-group
(0.02 (0.04) μg/Kg/minute) (P = 0.066). No statistically
significant differences were found in epinephrine dose
(P = 0.15), arginine-vasopressin dose (P = 0.56), heart rate
(P = 0.62) or ejection fraction of the left ventricle (pre-
operative measurement during routine risk stratification)
(P = 0.19) when comparing the two groups. The multi-
variate logistic regression included a total of 18 parame-
ters (3 anthropometric, 12 clinical, 2 pharmacologic, and
1 technical) (Table 5). The final analysis identified five
parameters independently associated with underdamp-
ing/resonance (Table 6): polydistrectual arteriopathy
(P = 0.0023), history of arterial hypertension (P = 0.0214),
chronic obstructive pulmonary disease (P = 0.0198), arter-
ial catheter diameter (20- versus 18-gauge) (P <0.0001),
and sedation (P = 0.0131). Heart rate (HR) was not corre-
lated with underdamping/resonance even after division
into three terciles (tercile-I including HR ≤73 b/minute,
P = 0.23; tercile-II including HR >73 and ≤84 b/minute,
P = 0.89; tercile-III including HR > 84 b/minute, P = 0.92).
According to the OR, three of these parameters resulted
from a predisposition to underdamping/resonance: poly-
distrectual arteriopathy (OR = 2.82), chronic obstructive
pulmonary disease (OR = 2.61), and arterial hypertension
(under drug therapy) (OR = 2.09). Two of them were pro-
tective: arterial catheter diameter (20- versus 18-gauge)
(OR = 0.35) and sedation (OR = 0.5). Finally, the receiver
operating characteristic (ROC) curve for the maximal
pressure-time ratio (dP/dtMAX), showed an optimum se-
lected cutoff point of 1.67 mmHg/msec with a specificity
of 97% (95% CI: 95.13 to 99.47%), a sensitivity of 77%
(95% CI: 67.25 to 85.28%), and an area under the ROC
curve by extended trapezoidal rule of 0.88 (Figure 5).
Discussion
Technical details of the physical properties of fluid-filled
catheter-transducer systems are described elsewhere.
Some information on this may nevertheless be useful in,m2 (SD); range LVEF-, % (SD); range HR, beats/minute (SD);
range
4 (0.18); 1.3 to 2.55 55 (11); 20 to 76 77.4 (13.9); 37 to 140
2 (0.15); 1.3 to 2.16 60 (7) 30 to 75 67.1 (13.3); 37 to 98
6 (0.19); 1.44 to 2.51 54 (11); 20 to 75 78.2 (13.4); 43 to 115
4 (0.19); 1.41 to 2.55 53 (11); 20 to 76 82 (11.7); 54 to 140
Table 3 Blood pressure measurements
Overall R-group NR-group
Systolic IBP mmHg (SD); range 134 (32); 78 to 241 157 (33); 82 to 241 124 (27); 78 to 240
Systolic NIBP mmHg (SD); range 122 (26); 76 to 238 129 (26); 76 to 191a 120 (27); 76 to 238b
Δ Systolic BP mmHg (SD); range 13 (14); −11 to 77 28 (16); 2 to 77 4 (5); −15 to 15
Diastolic IBP mmHg (SD); range 64 (13); 31 to 123 64 (12); 40 to 101 63 (13); 31 to 123
Diastolic NIBP mmHg (SD); range 66 (14); 32 to 132 69 (14); 43 to 98C 64 (13); 32 to 132d
Δ Diastolic BP mmHg (SD); range 2 (9); −27 to 82 −2 (11); −39 to 10 −1 (6); −17 to 14
Mean IBP mmHg (SD); range 83 (18); 37 to 155 90 (19); 37 to 135 81 (17); 46 to 155
Mean NIBP mmHg (SD); range 79 (19); 37 to 166 82 (21); 37 to 155e 78 (18); 41 to 166f
Δ Mean BP mmHg (SD); range 5 (9); −20 to 44 7 (11); −20 to 44 2 (6); −13 to 20
aSystolic IBP R-group versus Systolic NIBP R-group: P <0.0001; bSystolic IBP NR-group versus Systolic NIBP NR-group: P <0.0001; CDiastolic IBP R-group versus
Diastolic NIBP R-group: P = 0.0002; dDiastolic IBP NR-group versus Diastolic NIBP NR-group: P = 0.0018; eMean IBP R-group versus Mean NIBP R-group: P <0.0001;
fMean IBP NR-group versus Mean NIBP NR-group: P <0.0001. Sys, systolic; IBP, invasive blood pressure monitoring; NIBP, non-invasive blood pressure monitoring;
Dia, diastolic; Δ, difference; R-group, resonance group; NR-group, non-resonance group.
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posing or protecting factors and the artifact [10,14].
Briefly, once an artery has been cannulated, the pulse
generated by the left ventricle and transmitted via the ar-
terial tree flows from an indwelling catheter through
fluid-filled capillary tubing. The transduced pressure
causes displacement of the transducer membrane, con-
verting blood pressure - a time-varying physiologic event
- into an electrical signal via a resistive bridge. The elec-
trical signal is amplified and then digitally displayed. For
a faithful representation of the arterial pressure wave-
form and pressure values, the Fn of oscillation of the
transducer system (the frequency of unforced vibrations
or the frequencies at which an object tends to vibrate
when disturbed in the absence of damping forces) must
exceed the frequencies of the impulses generated by the
cardiovascular system (harmonics). When one of the fre-
quencies generated by the cardiovascular system overlaps
the Fn of the transducer, the underdamping/resonance
phenomenon occurs. Therefore, the Fn and the β (how
quickly the system comes to rest after being disturbed)
constitute the dynamic response characteristics of the
monitoring system. These in turn determine the system? sTable 4 Comparison of blood pressure using the
Bland-Altman method
Bias,
mmHg
Limits of
agreement,
mmHg
R-group systolic IBP versus systolic NIBP 28.5 −2.92 to 59.58
NR-group systolic IBP versus systolic NIBP 4.1 −6.19 to 14.40
R-group diastolic IBP versus diastolic NIBP −2.2 −23.42 to 14.81
NR-group diastolic IBP versus diastolic NIBP −1.1 −12.5 to 10.3
R-group mean IBP versus mean NIBP 7.4 −14.98 to 29.50
NR-group mean IBP versus mean NIBP 2.3 −13.09 to 17.69
R-group, resonance group; NR-group, non-resonance group; IBP, invasive blood
pressure monitoring; NIBP, non-invasive blood pressure monitoring.ability to reproduce arterial waveform without distortion.
The underdamping/resonance phenomenon can hence be
defined as the tendency of a system to oscillate with
greater amplitude at some frequencies than at others.
The results of the present study confirm our previous
clinical observation that the occurrence of underdamp-
ing/resonance is present in about 30% of critically ill pa-
tients. This artifact is probably frequently overlooked
but may have clinical relevance and may lead to in-
appropriate therapeutic approaches if the artifact is not
recognized and corrected [7]. It must be emphasized
that a scarce body of literature is currently evaluating
the accuracy of IBP with modern transducers and moni-
tors. On the other hand, according to our data, patients
with a resonant arterial waveform according to Gardner ? s
test [9] appeared to have significantly different NIBP
measurements that, in these conditions, may be consid-
ered the most reliable one [14].
In fact, the IBP-NIBP difference in NR patients was
clinically irrelevant, indicating that NIBP might be con-
sidered a reliable and accurate method even in the ICU,
with the exception of certain specific conditions (for ex-
ample, obese patients, extreme hypotension, arrhyth-
mias) [15,16]. As further confirmation of this, a recently
published survey of blood pressure monitoring showed
NIBP to be commonly used by a large number of ICU
physicians in the United States [4]. In our cohort of pa-
tients, we found a rather homogeneous distribution of
underdamping/resonance among the three groups, with
Sys values being the most affected when compared to
NIBP. In fact, in patients with underdamping/resonance,
Sys-IBP severely overestimated Sys-NIBP with a bias as
high as 28.5 mmHg, and ranging from 2 to 77 mmHg
(Figure 4). The extent of the bias was less pronounced
for Dia-IBP versus Dia-NIBP ( ? 2.2 mmHg) but still con-
sistent for Mean-IBP versus Mean-NIBP (7.4 mmHg).
This fact is of utmost importance for physicians because
Figure 4 Bland-Altman plots in the resonance (R-group) (a, c, e) and the non-resonance (NR)-group (b, d, f). Sys, systolic; Dia, diastolic;
IBP, invasive blood pressure monitoring; NIBP, non-invasive blood pressure monitoring.
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ommended the optimization of both systolic and mean
arterial pressure in order to improve tissue perfusion in
the ICU [3,5,17]. In these conditions, the inaccurate
measurement of arterial blood pressure may cause in-
appropriate interventions such as a lack of fluids and/or
vasoactive/inotropic support in true hypotension, or the
treatment of false systolic hypertensions with a conse-
quent reduction in tissue perfusion pressure. A differ-
ence >10 mmHg with actual arterial pressure is clinicallyrelevant, and >20 mmHg is clinically unacceptable [7].
Interestingly, in the NR-group, the bias of the Sys, Dia,
and Mean BP between IBP and NIBP was very limited
(4.1, ? 1.1 and 2.3 mmHg respectively). This concurs with
existing literature [12,18].
In our cohort of patients, the multivariate analysis
identified five conditions independently correlated with
underdamping/resonance: three clinical conditions (chronic
arterial hypertension, polydistrectual arteriopathy and
chronic obstructive pulmonary disease (COPD)), one
Table 5 Logistic regression - backward selection
(18 parameters)
Variable P-value
Anthropometric
Age 0.7077
Sex 0.2404
Body surface area 0.4456
Clinical
Polydistrectual arteriopathy 0.0025
Coronary artery disease 0.2651
Valvular disease 0.8716
Abdominal aortic aneurysm 0.6594
Carotid artery disease 0.3624
History of arterial hypertension 0.0836
Non-insulin dependent diabetes mellitus 0.1804
Chronic renal failure 0.7213
Chronic obstructive pulmonary disease 0.0082
Left ventricle ejection fraction 0.4889
Heart rate (beats/minute) 0.5753
Core temperature 0.1233
Pharmacologic
Sedation 0.0078
Norepinephrine infusion 0.1142
Technical
Catheter diameter (18- or 20-gauage) <0.0001
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eter (arterial catheter diameter and length). We found that
hypertensive arteriopathy is a predisposing factor for
underdamping/resonance: this result confirms the findings
of our previous work in vascular surgery patients [10]. It
is currently uncertain what this strong association de-
pends on: however, as it may be a consequence of the
high stiffness of the arterial system that may contribute
to the generation of high frequency harmonics eventually
overlapping the Fn of the catheter-tubing-manometer
system. In support of this, we found that polydistrectual
arteriopathy and arterial hypertension were independ-
ently associated with underdamping/resonance artifacts
with an OR of 2.82 (P = 0.0023) and 2.09 (P = 0.021)Table 6 Logistic regression - backward selection
Parameter P-value Odds
ratio
95% CI
Polydistrectual arteriopathy 0.0023 2.82 1.45 to 5.50
Chronic obstructive pulmonary disease 0.0198 2.61 1.16 to 5.87
Arterial hypertension 0.0214 2.09 1.12 to 3.93
Arterial catheter 20- versus 18-gauge <0.0001 0.35 0.21 to 0.58
Sedation 0.0131 0.5 0.29 to 0.86respectively. COPD has been found to be correlated with
underdamping/resonance (OR = 2.61; P = 0.0198). This
association may be explained with the hypothesis that ar-
terial hypertension and atherosclerosis, both associated
with underdamping/resonance and frequently affecting
COPD patients [19], may have been missed in the med-
ical history. On the contrary, sedation has a protective
role (OR = 0.5; P = 0.013), as the reduction in vascular
tone caused by a direct effect on the vessels ? smooth
muscles and attenuation of the sympathetic nervous sys-
tem limits the development of high frequency harmonics
[10,20]. Finally, the length and, mainly, the diameter of
the arterial catheter play a key role in the development of
underdamping/resonance artifacts. This phenomenon
can be clearly explained by looking at the following equa-
tion for the damping coefficient (β) [21]:
β ? 4μ=r3 ρL=πE? ? 1=2
Here, β is the damping coefficient (entity of friction
forces), μ is the viscosity of the fluid, r is the internal ra-
dius of the catheter, ρ is the density of the fluid, L is the
length of the catheter, and E is the elasticity of the sys-
tem. By increasing the internal radius (r) of the catheter
(that is, by replacing a 20-gauge with an 18-gauge cath-
eter), the damping coefficient (β) decreases significantly
as it varies inversely to the cube of the radius. Similarly,
by increasing the length of the catheter (L), β also in-
creases. Moreover, as the physical properties of the
catheter-tubing-manometer system determine the Fn ac-
cording to the following formula [14]:
Fn ? 1=2π √k=m
(where k is the elasticity and m is the mass), by changing
the length and the diameter of the arterial cannula, the
Fn changes as well.
Our data show a strong relationship between catheter
diameter and length and underdamping/resonance, with
smaller catheters demonstrating a highly protective ef-
fect (20- versus 18-gauge; OR = 0.35; P <0.0001). When
an arterial line is put in place, this fact should certainly
be taken into consideration. Equally, eventual fibrin de-
position may, with time, increase β. Lambermont et al.
developed, in an experimental setting, a mathematical
transfer function that, by adjusting the natural frequency
and the damping coefficient of the fluid-filled catheter
system, may reconstruct the pressure waveform free of
artifacts [22]. At a practical level, however, it is very im-
portant for the clinician to be aware of the high inci-
dence of underdamped/resonant arterial waveforms in
critically ill adult patients. Non-invasive systolic pressure
measurement may be helpful to suspect and identify this
artifact at the bedside. Newer hemodynamic monitors
measure the dP/dtMAX as an indicator of myocardial
Figure 5 Receiver operating characteristic curve for maximal pressure-time ratio (DP/dtMAX).
Romagnoli et al. Critical Care 2014, 18:644 Page 9 of 11
http://ccforum.com/content/18/6/644contractility [23,24]. In 2011, we observed that dP/dtMAX
in arterial signal affected by underdamping/resonance
was significantly higher than in artifact-free waveforms
[10]. In the present study, we performed a ROC curve
analysis in order to identify a predicting value for under-
damping/resonance. The ROC curve showed that a thresh-
old value of 1.67 could discriminate an underdamped/
resonant signal from a non-underdamped/non-resonant
signal with a specificity of 97% (95% CI: 95.13 to 99.47%),
a sensitivity of 77% (95% CI: 67.25 to 85.28%), and an area
under the ROC curve by extended trapezoidal rule of 0.88.
Therefore, a dP/dtMAX greater than 1.67 may be helpful in
identifying suspected underdamped/resonant signals prior
to the performance of a fast-flush test. Moreover, in light
of our results, the comparison of Sys-IBP and Sys-NIBP
may have a strong predictive value for the identification of
resonance-affected waveforms.
Finally, we acknowledge several weaknesses. First, the
oscillometric method for NIBP measurement is not stan-
dardized. Algorithms for systolic and diastolic pressure
estimation may differ from manufacturer to manufac-
turer, and even from device to device [6]. We used a
modern and quite diffuse system; however, different
monitors could have given different data to some extent.
Second, severe hypotension is commonly recognized as
limiting the accuracy of NIBP, although recent data call
this statement into question [12]. In our observational
study, systolic pressures <70 mmHg did not appear in
the final analysis. Third, IBP and NIBP were not regis-
tered pairwise at precisely the same time but one mo-
mentarily after the other. This was because we preferred
to use the same arm in order to avoid differences related
to vascular stenosis or for other reasons related to differ-
ent pulse transmission. However, it is unlikely that thismethodology caused significant differences in blood pres-
sure due to sudden changes in patients? clinical conditions.
Fourth, arterial stiffness is one of the conditions in which
NIBP usually overestimates the true arterial pressure [6].
Many of our patients were affected by polydistrectual
arteriopathy commonly characterized by increased arterial
stiffness. This last could be considered a limitation of the
study, although in those patients with underdamping/res-
onance, IBP resulted in the overestimation of NIBP. In
light of this, it may be speculated that our results repre-
sent an underestimation, and that the actual IBP-NIBP dif-
ferences could be even higher in patients with resonance.
Finally, our observations cannot be generalized to include
the patient population excluded from the study. Among
these, we acknowledge obese patients for whom NIBP
measurements were shown to be inaccurate [8], patients
with arrhythmias, and patients with high doses of vaso-
constrictors. Vasoconstrictors can be involved in under-
damping/resonance phenomena. Nonetheless, our analysis
did not identify norepinephrine administration as a cor-
related factor [20]. However, it should be underlined
that the norepinephrine doses administered in both
groups were quite low (≤0.02 μg/Kg/minute), and that
the difference between groups was not statistically sig-
nificant (P = 0.066). Finally, it is likely that low-dose
norepinephrine may have played a minor role in the de-
velopment of underdamping/resonance. It is reasonable
to speculate that higher doses (for example, septic pa-
tients), may lead to different effects.
Conclusions
In conclusion, IBP remains the gold standard for arterial
pressure monitoring in critically ill patients. However, as
faithful representation of arterial waveform and blood
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sive care, anesthesia, and modern medicine, the phys-
ician should be aware of the possibility that IBP can be
overestimated in a consistent number of patients. NIBP
may help to confirm/exclude the presence of under-
damping phenomena and avoid inopportune treatments.
Key messages
 Invasive blood pressure monitoring, free of artifacts,
is the gold standard for arterial pressure
measurement in critically ill patients
 Underdamping/resonance artifacts may alter blood
pressure values in about one third of critically ill
patients
 Physicians should always test arterial pressure
waveform for underdamping/resonance artifacts
 The presence of a systolic invasive arterial pressure
greater than 15 to 20 mmHg in respect of the
non-invasive technique (or a dP/dtMAX greater than
1.67 mmHg/msec) may help to identify the presence
of underdamping phenomena
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